Quantification of MDM2 transcripts in primary ALL samples confirms that the respective levels are significantly more abundant in E/R-positive (n=12) than in E/R-negative (n=11) cases (Figure 1c, right). Here, MDM2 is linked to acute lymphoblastic leukemia.